Assessment of patients’ preferences for new anticancer drugs in China: a best–worst discrete choice experiment on three common cancer types

OBJECTIVES: Despite the advancement in anticancer drug therapies, cancer treatment decisions are often complex and preference-sensitive, making them well suited for studying shared decision-making (SDM). Our study aimed to assess preferences for new anticancer drugs among three common types of patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Zhe, Meng, Jingyi, Sun, Yanjun, Xie, Tongling, Lu, Wenzhang, Wang, Guohua, Geng, Jinsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Patient-Centred Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254615/
https://www.ncbi.nlm.nih.gov/pubmed/37270199
http://dx.doi.org/10.1136/bmjopen-2023-072469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254615/
https://www.ncbi.nlm.nih.gov/pubmed/37270199
http://dx.doi.org/10.1136/bmjopen-2023-072469

Ejemplares similares